Exploring the use of optical coherence tomography and hyperspectral imaging in glioma detection during surgery

Exploring the use of optical coherence tomography and hyperspectral imaging in glioma detection during surgery - OCT and HSI in glioma surgery

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON44150

Enrollment

Registered

2016-02-03

Start date

2016-03-11

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

glioma

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: glioma and planned surgery

Exclusion criteria

Exclusion criteria: Histopathological diagnoses is not glioma

Design outcomes

Primary

Measure	Time frame
Comparison of average spectrum of tumour tissue and healthy brain (cortical and subcortical) for HSI. Comparison of image characteristics of tumour tissue and healthy brain (cortical and subcortical) for OCT.	—

Secondary

Measure	Time frame
In each dataset (HSI and OCT) clusters of characteristics will be examined that result in most efficient detection of tumour tissue.	—

Countries

Netherlands

Outcome results